United Guardian (UG) Other Non-Current Assets (2010 - 2020)
United Guardian's (UG) quarterly Other Non-Current Assets came in at $3706.0 in Q3 2020, down 80.0% year-over-year from $18530.0 in Q4 2019, and down 50.0% quarter-over-quarter from $7412.0 in Q2 2020.
Analysis
United Guardian (UG) Other Non-Current Assets (2010 - 2020) Analysis & Trends
United Guardian has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $3706.0 for Q3 2020.
- In Q3 2020, Other Non-Current Assets fell 80.0% year-over-year to $3706.0; the TTM figure through Sep 2020 stood at $3706.0 (down 80.0% YoY), while the FY2019 annual figure was $14824.0, down 50.0% from the prior year.
- Other Non-Current Assets came in at $3706.0 for Q3 2020 at United Guardian, down from $7412.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $70413.0 in Q1 2016 to a low of $3706.0 in Q3 2020.
- Average Other Non-Current Assets over 5 years is $37848.6, with a median of $37059.0 recorded in 2018.
- Year-over-year, Other Non-Current Assets increased 0.3% in 2017 and plunged 80.0% in 2020.
- Over 5 years, Other Non-Current Assets stood at $59295.0 in 2016, then rose by 0.3% to $59471.0 in 2017, then sank by 50.15% to $29647.0 in 2018, then plunged by 50.0% to $14824.0 in 2019, then plunged by 75.0% to $3706.0 in 2020.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $3706.0 in Q3 2020, $7412.0 in Q2 2020, and $11118.0 in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.68 Bn | 624.92 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 441.40 Bn | 434.83 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 365.79 Bn | 358.65 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 266.44 Bn | 258.75 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Pfizer | 158.97 Bn | 147.27 Bn | 10.94 Bn | 9.94 Bn |
| 6 | Sanofi | 52.38 Bn | 45.00 Bn | 10.79 Bn | 5.50 Bn |
| 7 | Revolution Medicines | 44.09 Bn | 44.09 Bn | - | 42.45 Mn |
| 8 | Incyte | 25.52 Bn | 20.99 Bn | 1.57 Bn | 86.76 Mn |
| 9 | United Therapeutics | 21.52 Bn | 18.86 Bn | 683.80 Mn | 239.50 Mn |
| 10 | United Guardian | 32.46 Mn | 22.87 Mn | 1.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 3,706.00 |
| Jun 30, 2020 | 7,412.00 |
| Mar 31, 2020 | 11,118.00 |
| Dec 31, 2019 | 14,824.00 |
| Sep 30, 2019 | 18,530.00 |
| Jun 30, 2019 | 22,235.00 |
| Mar 31, 2019 | 25,941.00 |
| Dec 31, 2018 | 29,647.00 |
| Sep 30, 2018 | 33,353.00 |
| Jun 30, 2018 | 37,059.00 |
| Mar 31, 2018 | 40,765.00 |
| Dec 31, 2017 | 59,471.00 |
| Sep 30, 2017 | 48,177.00 |
| Jun 30, 2017 | 51,883.00 |
| Mar 31, 2017 | 55,588.00 |
| Dec 31, 2016 | 59,295.00 |
| Sep 30, 2016 | 63,000.00 |
| Jun 30, 2016 | 66,707.00 |
| Mar 31, 2016 | 70,413.00 |
| Dec 31, 2015 | 74,118.00 |